* Creative Medical Technology Holdings Inc reported a quarterly adjusted loss of $1.11 per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of -78 cents. The lone analyst forecast for the quarter was for a loss of 84 cents per share.
* Revenue was $8.00 thousand; analysts expected zero.
* Creative Medical Technology Holdings Inc's reported EPS for the quarter was a loss of $1.11.
* The company reported a quarterly loss of $1.56 million.
* Creative Medical Technology Holdings Inc shares had fallen by 21.6% this quarter and lost 34.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 27.6% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for Creative Medical Technology Holdings Inc is $30.00 This summary was machine generated from LSEG data August 10 at 09:40 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.84 -1.11 Missed
Mar. 31 2024 -1.15 -0.73 Beat
Dec. 31 2023 -1.13 -1.19 Missed
Sep. 30 2023 -0.86 -1.02 Missed
Comments